## Abstract ## Background The present analyses were conducted to examine the extent to which insulin sensitivity and insulin secretion, assessed using simple indices derived from an oral glucose tolerance test, are influenced by genetic factors, and to assess whether these genetic factors overlap
Role of amylin in insulin secretion and action in humans: antagonist studies across the spectrum of insulin sensitivity
✍ Scribed by Kieren J. Mather; Giancarlo Paradisi; Rosalind Leaming; Ginger Hook; Helmut O. Steinberg; Naomi Fineberg; Rochelle Hanley; Alain D. Baron
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 241 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1520-7552
- DOI
- 10.1002/dmrr.263
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background
Amylin is a peptide co‐secreted with insulin by pancreatic β‐cells. A role for amylin in the pathogenesis of type 2 diabetes mellitus (DM2) has been suggested by in vitro and in vivo studies indicating an effect of amylin to cause insulin resistance and/or inhibit insulin secretion.
Methods
We have determined the effect of endogenous amylin on insulin secretion and insulin action in humans by performing 4‐h hyperglycemic clamps during infusion of placebo or a specific amylin receptor antagonist (ARA) in paired, double‐blinded, crossover studies. We studied nine healthy lean, ten healthy obese (BMI>27) and ten obesity‐matched DM2 subjects.
Results
Infusion of ARA alone had no effect on basal insulin, glucose or glucose turnover in any group. Under combined hyperglycemia and ARA infusion, lean subjects displayed a 32% augmentation in insulin levels [AUC 33 565±3556 (placebo) to 44 562±1379 (ARA) pmol/l/min, p<0.01]. The concomitant increase in glucose disposal rate (GDR) was proportionate, indicating no change in insulin sensitivity (ISI 27.7±2.7 vs 27.3±2.1, p=NS). In obese subjects, basal insulin and the rise in insulin during the clamp were greater (AUC I 44% increase from 82 054±15 407 to 117 922±27 085, p<0.01), and also accompanied by a proportionate rise in GDR reflecting an unchanged insulin sensitivity (ISI 12.1±2.9 vs 10.8±3.0, p=NS). In lean and obese subjects, the C‐peptide response to hyperglycemia was also augmented by ARA (p=0.007). No effect of ARA on insulin secretion or action was observed in diabetic subjects.
Conclusions
The present data are consistent with an effect of endogenous amylin on the β‐cell to modulate and/or restrain insulin secretion, and indicate that endogenous amylin does not affect insulin action. These observations provide the first human evidence that amylin plays a role in the modulation of insulin secretion. Copyright © 2002 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract Ion channels in beta cells regulate electrical and secretory activity in response to metabolic, pharmacologic, or neural signals by controlling the permeability to K^+^ and Ca^2+^. The ATP‐sensitive K^+^ channels act as a switch that responds to fuel secretagogues or sulfonylureas to in
Insulin has both short- and long-term effects on cellular metabolism. The short-term effects are known to involve the insulin receptor, a protein kinase capable of phosphorylating itself and other proteins. The role of the receptor was elucidated by studies of a mutant insulin receptor which lacked
Insulin has diverse effects on cells, including stimulation of glucose transport, gene expression, and alterations of cell morphology. The hormone mediates these effects by activation of signaling pathways which utilize, 1) adaptor molecules such as the insulin receptor substrates (IRS), the Src and
In the present study, we attempted to determine the importance of a 23-amino-acid sequence within the carboxyl terminus of the human insulin receptor (IR) molecule in modulating insulin action in Chinese hamster ovary cells. Stable expression of a minigene encoding the receptor fragment led to an in
## Abstract Dietary fatty acids play an important role in the development of insulin resistance, the prelude to type 2 diabetes mellitus. This review addresses the potential role of olive oil‐derived MUFA in insulin sensitivity, particularly how dietary fat interacts with insulin resistance looking